心脏再同步化治疗心力衰竭的死亡原因分析

    Analysis of death causes of heart failure patients received cardiac resynchronization therapy

    • 摘要: 目的:探讨心脏再同步化治疗(cardiac resynchronization therapy,CRT)心力衰竭患者的死亡原因。方法:53例NYHA心功能Ⅲ~Ⅳ级的药物难治性心力衰竭患者均成功置入CRT系统,术后常规应用标准抗心力衰竭药物。随访1~80个月,观察患者病情变化及结果。结果:7例死亡,其中5例为心源性死亡,2例为非心源性死亡。心源性死亡主要是心功能恶化和心律失常所致。心功能恶化与基础心脏病和术后心房颤动的发生有关。结论:CRT患者的死亡有多种类型,其中心源性死亡与基础心脏疾病和术后房颤的发生有关。

       

      Abstract: Objective: To explore the causes of death in patients with heart failure who have received cardiac resynchronization therapy(CRT).Methods: Fifty-three patients with NYHA class Ⅲ or Ⅳ heart failure who had failed to respond to standard pharmacologic therapy were treated by CRT.The routine medicine was applied after the operation.The follow-up lasted from 1 to 80 months,and the outcome was observed.Results: Seven patients died during the follow-up,5 of whom were cardiac death and 2 non-cardiac death.Cardiac death was mainly induced by deterioration of heart function and cardiac arrhythmia.Deterioration of heart function was related to primary heart disease and occurrence of atrial fibrillation.Conclusions: Causes of death in patients with CRT are varied and cardiac death is associated with the primary heart disease and the occurrence of atrial fibrillation.

       

    /

    返回文章
    返回